ERNA-201
/ Ernexa Therapeutics
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
November 10, 2025
Development Program Highlights: ERNA-201
(GlobeNewswire)
- "Anticipated a pre-IND meeting to obtain regulatory alignment by Q1 2026."
FDA event • Rheumatoid Arthritis
1 to 1
Of
1
Go to page
1